International Journal of Cardiology: Heart & Vasculature (Jun 2022)

Global longitudinal strain differentiates physiological hypertrophy from maladaptive remodeling

  • Yvonne Bewarder,
  • Lucas Lauder,
  • Saarraaken Kulenthiran,
  • Ortwin Schäfer,
  • Christian Ukena,
  • Robert Percy Marshall,
  • Pierre Hepp,
  • Ulrich Laufs,
  • Stephan Stöbe,
  • Andreas Hagendorff,
  • Michael Böhm,
  • Felix Mahfoud,
  • Sebastian Ewen

Journal volume & issue
Vol. 40
p. 101044

Abstract

Read online

Aims: Differentiation of left ventricular (LV) hypertrophy in healthy athletes from pathological LV hypertrophy in heart disease is often difficult. We explored whether extended echocardiographic measurements such as E/e’ and global longitudinal strain (GLS) distinguish physiologic from maladaptive hypertrophy in hypertrophic cardiomyopathy, excessively trained athletes’ hearts and normal hearts. Methods: Seventy-eight professional athletes (cyclists n = 37, soccer players n = 29, handball players n = 21) were compared with patients (n = 88) with pathological LV hypertrophy (hypertrophic obstructive cardiomyopathy (HOCM, n = 17), hypertensive heart disease (HHD, n = 36), severe aortic valve stenosis (AVS, n = 35) and with sedentary healthy individuals as controls (n = 37). Results: LV ejection fraction (LVEF) was ≥50% in all patients, athletes (median age 26 years, all male) and the controls (97% male, median age 32 years). LV mass index (LVMI) and septal wall thickness was in normal range in controls, but elevated in cyclists and patients with pathological hypertrophy (p 11 mm, GLS (≥−18%) has a specificity of 79% to distinguish between physiological and pathological hypertrophy. Conclusion: GLS and E/e’ are reliable parameters unlike left ventricular mass or LV ejection fraction to distinguish pathological and physiological hypertrophy.

Keywords